Holen Sie sich die Stockscreener-App
32.91
6.14%
1.855
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$31.05
Offen:
$31.73
24-Stunden-Volumen:
828.14K
Relative Volume:
0.98
Marktkapitalisierung:
$1.52B
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-329.05
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
+0.69%
1M Leistung:
-1.10%
6M Leistung:
+190.10%
1J Leistung:
+124.18%
1-Tages-Spanne:
$31.48
$33.72
1-Wochen-Bereich:
$30.32
$33.72
52-Wochen-Spanne:
$9.215
$34.24
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
32.88 | 1.43B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
127.09 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.88 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now? - Yahoo Finance
Axogen, Inc. (NASDAQ:AXGN) Could Be Less Than A Year Away From Profitability - simplywall.st
Growth Value: Is Axogen Inc stock affected by interest rate hikesQuarterly Market Review & AI Enhanced Trading Signals - moha.gov.vn
AxoGen (NASDAQ:AXGN) Stock Price Down 6.1%Time to Sell? - MarketBeat
AxoGen, Inc. $AXGN Shares Bought by HighMark Wealth Management LLC - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 17.8% in December - MarketBeat
Discipline and Rules-Based Execution in AXGN Response - Stock Traders Daily
Will Axogen Inc stock maintain dividend yieldWeekly Trading Summary & Advanced Technical Signal Analysis - moha.gov.vn
Rice Hall James & Associates LLC Sells 45,709 Shares of AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Shares Down 3%Here's What Happened - MarketBeat
Are Investors Undervaluing Axogen, Inc. (NASDAQ:AXGN) By 31%? - Yahoo Finance
Is Axogen Inc. stock affected by interest rate hikesWeekly Volume Report & Expert Curated Trade Setup Alerts - bolumsonucanavari.com
Assenagon Asset Management S.A. Grows Stake in AxoGen, Inc. $AXGN - MarketBeat
How interest rate cuts could boost Axogen Inc. stockTake Profit & AI Driven Stock Price Forecasts - Улправда
How Axogen Inc. stock benefits from global expansionMarket Sentiment Summary & Weekly Watchlist for Hot Stocks - Улправда
Axogen (FRA:LT3) EV-to-OCF : 227.22 (As of Dec. 19, 2025) - GuruFocus
Bull Run: Will Axogen Inc. stock outperform tech sector in 2025July 2025 Snapshot & Long-Term Capital Growth Ideas - Улправда
Will Axogen Inc. stock maintain dividend yieldMarket Movers & Fast Gaining Stock Reports - DonanımHaber
Why Axogen Inc. stock remains on buy listsInflation Watch & Stepwise Entry and Exit Trade Signals - DonanımHaber
Risk Analysis: How Axogen Inc. stock trades during market volatility2025 Market Outlook & Daily Growth Stock Tips - ulpravda.ru
Will Axogen Inc. stock benefit from commodity pricesJuly 2025 Setups & Community Verified Watchlist Alerts - Улправда
How Does Axogen Stock Compare With Peers? - Trefis
Lindsey Marie Hartley Sells 14,812 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Amy Mcbride Wendell Sells 43,684 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $1,378,596.15 in Stock - MarketBeat
Axogen Executives Conduct Significant Stock Transactions - TradingView — Track All Markets
[Form 4] Axogen, Inc. Insider Trading Activity - Stock Titan
Axogen (NASDAQ: AXGN) director exercises options and sells 46,653 shares - Stock Titan
Axogen, Inc. (AXGN) CFO reports option exercise and stock sale in Form 4 - Stock Titan
AxoGen (NASDAQ:AXGN) Stock Price Up 5.4%What's Next? - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference - The Manila Times
AXGN stock rises pre-market after FDA approves nerve repair graft - MSN
Axogen (AXGN): Reassessing Valuation After FDA BLA Approval for AVANCE Nerve Allograft - Sahm
Dir Weiler Files To Sell 46,653 Of Axogen Inc [AXGN] - TradingView — Track All Markets
Squarepoint Ops LLC Purchases 348,950 Shares of AxoGen, Inc. $AXGN - MarketBeat
With Axogen Stock Surging, Have You Considered The Downside? - Trefis
Would You Still Hold Axogen Stock If It Fell Another 30%? - Trefis
Axogen (AXGN) price target increased by 18.26% to 34.58 - MSN
Should FDA Biologic Approval of AVANCE Nerve Scaffold Require Action From Axogen (AXGN) Investors? - simplywall.st
Is Axogen Stock Built to Withstand More Downside? - Trefis
Leerink Partners raises AxoGen stock price target to $40 on BLA approval - Investing.com Nigeria
Can Axogen Stock Recover If Markets Fall? - Trefis
Insider Sell: Marc Began Sells Shares of Axogen Inc (AXGN) - GuruFocus
Leerink Partners raises AxoGen stock price target to $40 on BLA approval By Investing.com - Investing.com South Africa
Trade Alert: President Of Axogen Michael Dale Has Sold Stock - simplywall.st
Armistice Capital LLC Boosts Holdings in AxoGen, Inc. $AXGN - MarketBeat
Michael Dale Sells 61,463 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Paul Thomas Sells 21,399 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Joseph Tyndall Sells 25,108 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
AxoGen (NASDAQ:AXGN) CFO Sells $454,053.72 in Stock - MarketBeat
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):